PacBio enters research collaboration with National Cancer Centre of Singapore

PacBio announced the signing of a new Research Collaboration Agreement (RCA) with the National Cancer Centre of Singapore. This collaboration aims to accelerate cancer research by leveraging PacBio’s advanced sequencing technologies, including the innovative Onso short-read sequencing platform, to profile the genomic landscape of prevalent cancers in Asia. The research project will focus on profiling prevalent cancers in Asia using PacBio’s Onso short-read sequencing system and Kinnex long-read sequencing kit, with a particular emphasis on single-cell RNA sequencing. The Onso platform, known for its exceptional accuracy in short-read sequencing, will enable researchers to detect clinically relevant mutations across various cancer types, such as gastrointestinal stromal tumors. Its unique ability to deliver highly accurate data at scale makes it ideal for exploring genomic variants in cancer samples, ensuring robust analysis that could ultimately provide better cancer diagnostics and therapeutics. As part of the collaborative effort, PacBio’s authorized channel partner in Asia, DKSH, has installed the Onso platform at the Cancer Discovery Hub in NCCS, which is dedicated to expanding cancer research and discovery.